Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04484428 · ClinicalTrials.gov registry record · Phase 2
A Study to Evaluate the Efficacy and Safety of K-285 Compared With Menthol Gel for the Treatment of Delayed Onset Muscle Soreness (DOMS) in the Lower Extremity
A Phase 2 study, sponsored by Kowa Research Institute.
- Terminated
- Registry status
- Phase 2
- Development phase
- 126
- Enrollment target
NCT04484428 is a Phase 2 study that was terminated before completion, run by Kowa Research Institute. The registered enrollment target is 126 participants.
The verdict
NCT04484428, a Phase 2 study, was terminated before completion, sponsored by Kowa Research Institute.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 126 participants
- Enrollment target
Study Summary
The purpose of this study to evaluate the efficacy and safety of K-285 compared with menthol gel for the treatment of delayed onset muscle soreness (DOMS) in the lower extremity.
Interventions
- DRUG Menthol
- DRUG K-285
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2020-08-15 |
| Est. Completion | 2021-03-19 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04484428
The ClinicalTrials.gov registry entry for NCT04484428 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kowa Research Institute, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Menthol is the first listed.
NCT04484428 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04484428 about?
NCT04484428 is a clinical study titled "A Study to Evaluate the Efficacy and Safety of K-285 Compared With Menthol Gel for the Treatment of Delayed Onset Muscle Soreness (DOMS) in the Lower Extremity". The purpose of this study to evaluate the efficacy and safety of K-285 compared with menthol gel for the treatment of delayed onset muscle soreness (DOMS) in the lower extremity.
What is the current status of trial NCT04484428?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 126 participants. The study started on 2020-08-15. Estimated completion is 2021-03-19.
What interventions are being tested in trial NCT04484428?
The interventions under investigation include: Menthol (DRUG), K-285 (DRUG).
Who is sponsoring clinical trial NCT04484428?
This trial is sponsored by Kowa Research Institute, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.